These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
101 related articles for article (PubMed ID: 9525754)
1. Magnetic resonance imaging relaxation times and gadolinium-DTPA relaxivity values in human cerebrospinal fluid. Ibrahim MA; Emerson JF; Cotman CW Invest Radiol; 1998 Mar; 33(3):153-62. PubMed ID: 9525754 [TBL] [Abstract][Full Text] [Related]
2. Gd-DTPA T1 relaxivity in brain tissue obtained by convection-enhanced delivery, magnetic resonance imaging and emission spectroscopy. Haar PJ; Broaddus WC; Chen ZJ; Fatouros PP; Gillies GT; Corwin FD Phys Med Biol; 2010 Jun; 55(12):3451-65. PubMed ID: 20508321 [TBL] [Abstract][Full Text] [Related]
3. In vitro investigation of poor cerebrospinal fluid suppression on fluid-attenuated inversion recovery images in the presence of a gadolinium-based contrast agent. Bonzano L; Roccatagliata L; Levrero F; Mancardi GL; Sardanelli F Magn Reson Med; 2008 Jul; 60(1):220-3. PubMed ID: 18581384 [TBL] [Abstract][Full Text] [Related]
4. Evaluation of the integrity of the blood-brain barrier after meningeal trauma. Walker JD; Martin MA; Potts DG; Lemaire C; Templeton DM Invest Radiol; 1992 Apr; 27(4):298-301. PubMed ID: 1601620 [TBL] [Abstract][Full Text] [Related]
5. Intraindividual comparison of T1 relaxation times after gadobutrol and Gd-DTPA administration for cardiac late enhancement imaging. Doeblin P; Schilling R; Wagner M; Luhur R; Huppertz A; Hamm B; Taupitz M; Durmus T Eur J Radiol; 2014 Apr; 83(4):660-4. PubMed ID: 24433640 [TBL] [Abstract][Full Text] [Related]
6. Increased blood-brain barrier permeability in type II diabetes demonstrated by gadolinium magnetic resonance imaging. Starr JM; Wardlaw J; Ferguson K; MacLullich A; Deary IJ; Marshall I J Neurol Neurosurg Psychiatry; 2003 Jan; 74(1):70-6. PubMed ID: 12486269 [TBL] [Abstract][Full Text] [Related]
7. Quantitative evaluation of blood-cerebrospinal fluid barrier permeability in the rat with experimental meningitis using magnetic resonance imaging. Ichikawa H; Ishikawa M; Fukunaga M; Ishikawa K; Ishiyama H Brain Res; 2010 Mar; 1321():125-32. PubMed ID: 20114032 [TBL] [Abstract][Full Text] [Related]
8. T1 relaxivities of gadolinium-based magnetic resonance contrast agents in human whole blood at 1.5, 3, and 7 T. Shen Y; Goerner FL; Snyder C; Morelli JN; Hao D; Hu D; Li X; Runge VM Invest Radiol; 2015 May; 50(5):330-8. PubMed ID: 25658049 [TBL] [Abstract][Full Text] [Related]
9. Feasibility of texture analysis for the assessment of biochemical changes in meniscal tissue on T1 maps calculated from delayed gadolinium-enhanced magnetic resonance imaging of cartilage data: comparison with conventional relaxation time measurements. Mayerhoefer ME; Welsch GH; Riegler G; Mamisch TC; Materka A; Weber M; El-Rabadi K; Friedrich KM; Dirisamer A; Trattnig S Invest Radiol; 2010 Sep; 45(9):543-7. PubMed ID: 20661144 [TBL] [Abstract][Full Text] [Related]
10. Development of Bifunctional Gadolinium-Labeled Superparamagnetic Nanoparticles (Gd-MnMEIO) for In Vivo MR Imaging of the Liver in an Animal Model. Kuo YT; Chen CY; Liu GC; Wang YM PLoS One; 2016; 11(2):e0148695. PubMed ID: 26886558 [TBL] [Abstract][Full Text] [Related]
11. [The observation of blood-brain barrier of organic mercury poisoned rat: a Gd-DTPA enhanced magnetic resonance study]. Kuwabara T; Yuasa T; Hidaka K; Igarashi H; Kaneko K; Miyatake T No To Shinkei; 1989 Jul; 41(7):681-5. PubMed ID: 2818908 [TBL] [Abstract][Full Text] [Related]
12. Magnetic resonance imaging of focal liver lesions. Comparison of the superparamagnetic iron oxide resovist versus gadolinium-DTPA in the same patient. Vogl TJ; Hammerstingl R; Schwarz W; Kümmel S; Müller PK; Balzer T; Lauten MJ; Balzer JO; Mack MG; Schimpfky C; Schrem H; Bechstein WO; Neuhaus P; Felix R Invest Radiol; 1996 Nov; 31(11):696-708. PubMed ID: 8915751 [TBL] [Abstract][Full Text] [Related]
13. [The effect of Gd-DTPA on magnetic resonance imaging: a potential blood-brain barrier indicator]. Hashimoto K; Yamagata S; Minamikawa J; Watanabe Y; Kanesiro M; Kikuchi H No To Shinkei; 1988 May; 40(5):461-6. PubMed ID: 3415864 [TBL] [Abstract][Full Text] [Related]
14. Contrast enhancement of the cerebrospinal fluid on MRI in two cases of spirochaetal meningitis. Good CD; Jäger HR Neuroradiology; 2000 Jun; 42(6):448-50. PubMed ID: 10929307 [TBL] [Abstract][Full Text] [Related]
15. Factors determining the proton T1 relaxivity in solutions containing Gd-DTPA. Aime S; Nano R Invest Radiol; 1988 Sep; 23 Suppl 1():S264-6. PubMed ID: 3198359 [TBL] [Abstract][Full Text] [Related]
16. [Changes in tissue T1 of brain tumor following GD-DTPA administration--differences in T1 time course and tissue-blood ratio by histological types]. Yoshida K; Furuse M; Kaneoke Y; Sasou K; Motegi Y No To Shinkei; 1988 Jun; 40(6):531-7. PubMed ID: 3224029 [TBL] [Abstract][Full Text] [Related]
17. Paramagnetic perfluorocarbon-filled albumin-(Gd-DTPA) microbubbles for the induction of focused-ultrasound-induced blood-brain barrier opening and concurrent MR and ultrasound imaging. Liao AH; Liu HL; Su CH; Hua MY; Yang HW; Weng YT; Hsu PH; Huang SM; Wu SY; Wang HE; Yen TC; Li PC Phys Med Biol; 2012 May; 57(9):2787-802. PubMed ID: 22510713 [TBL] [Abstract][Full Text] [Related]
18. In vivo biochemical 7.0 Tesla magnetic resonance: preliminary results of dGEMRIC, zonal T2, and T2* mapping of articular cartilage. Welsch GH; Mamisch TC; Hughes T; Zilkens C; Quirbach S; Scheffler K; Kraff O; Schweitzer ME; Szomolanyi P; Trattnig S Invest Radiol; 2008 Sep; 43(9):619-26. PubMed ID: 18708855 [TBL] [Abstract][Full Text] [Related]
19. Hepatic kinetics and magnetic resonance imaging of gadolinium-EOB-DTPA in dogs. Benness G; Khangure M; Morris I; Warwick A; Burrows P; Vogler H; Weinmann HJ Invest Radiol; 1996 Apr; 31(4):211-7. PubMed ID: 8721960 [TBL] [Abstract][Full Text] [Related]
20. 1H-NMR relaxation times and water compartmentalization in experimental tumor models. Braunschweiger PG; Schiffer LM; Furmanski P Magn Reson Imaging; 1986; 4(4):335-42. PubMed ID: 3669948 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]